GlassScriptPhysician profile
Larry A Reece
NPI 1801559588
$1,037.13
in general payments reported to CMS, 2019-2025
14 companies · $350 in 2025
The $350 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.49 · 2022: $258 · 2023: $274 · 2024: $142 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $666 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $666.08 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $356.85 | 2022-2025 | Lifevest |
| Pfizer INC. | $188.26 | 2022-2025 | |
| Amgen INC. | $156.04 | 2022-2024 | Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $99.99 | 2023 | Brilinta |
| Merck Sharp & Dohme LLC | $73.76 | 2022-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $27.44 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $23.27 | 2024 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $22.35 | 2025 | |
| Cvrx, INC. | $16.75 | 2023 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $15.46 | 2025 | Eliquis |
| Novo Nordisk INC | $15.22 | 2025 | Wegovy |
| Vital Connect, INC | $14.22 | 2023 | Vitalpatch Rtm |
| Angiodynamics, INC. | $14.03 | 2022 | |
| Medtronic, INC. | $13.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Reece listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.